Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eli Chapman

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Natural Product Reports|May 14, 2020
The role of natural products in revealing NRF2 functionDonna D Zhang, Eli Chapman
Bioorganic & Medicinal Chemistry|January 30, 2002
A pH sensitive colorometric assay for the high-throughput screening of enzyme inhibitors and substrates: a case study using kinasesEli Chapman, Chi-Huey Wong
Journal of Medicinal Chemistry|May 19, 2021
Function, Therapeutic Potential, and Inhibition of Hsp70 ChaperonesAndrew J Ambrose, Eli Chapman
Seminars in Cancer Biology|June 8, 2021
Targeting NRF2 to treat cancerJared Sivinski, Donna D Zhang, Eli Chapman
Molecular Biosystems|December 15, 2010
The complexities of p97 function in health and diseaseEli Chapman, Anastasia N Fry, MinJin Kang
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2003
Mechanistic studies of beta-arylsulfotransferase IVEli Chapman, Marian C Bryan, Chi-Huey Wong
Oncotarget|November 27, 2018
eIF4A inhibition: ready for primetime?Tyler A Cunningham, Eli Chapman, Jonathan H Schatz
Journal of the American Chemical Society|December 6, 2002
A potent and highly selective sulfotransferase inhibitorEli Chapman, Sheng Ding, Peter G Schultz, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2008
A small molecule inhibitor selective for a variant ATP-binding site of the chaperonin GroELEli Chapman, George W Farr, Krystyna Furtak, et al.
Cancer Cell|May 8, 2018
NRF2 and the Hallmarks of CancerMontserrat Rojo de la Vega, Eli Chapman, Donna D Zhang
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Natural Product Reports|May 14, 2020
The role of natural products in revealing NRF2 functionDonna D Zhang, Eli Chapman
Bioorganic & Medicinal Chemistry|January 30, 2002
A pH sensitive colorometric assay for the high-throughput screening of enzyme inhibitors and substrates: a case study using kinasesEli Chapman, Chi-Huey Wong
Journal of Medicinal Chemistry|May 19, 2021
Function, Therapeutic Potential, and Inhibition of Hsp70 ChaperonesAndrew J Ambrose, Eli Chapman
Seminars in Cancer Biology|June 8, 2021
Targeting NRF2 to treat cancerJared Sivinski, Donna D Zhang, Eli Chapman
Molecular Biosystems|December 15, 2010
The complexities of p97 function in health and diseaseEli Chapman, Anastasia N Fry, MinJin Kang
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2003
Mechanistic studies of beta-arylsulfotransferase IVEli Chapman, Marian C Bryan, Chi-Huey Wong
Oncotarget|November 27, 2018
eIF4A inhibition: ready for primetime?Tyler A Cunningham, Eli Chapman, Jonathan H Schatz
Journal of the American Chemical Society|December 6, 2002
A potent and highly selective sulfotransferase inhibitorEli Chapman, Sheng Ding, Peter G Schultz, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2008
A small molecule inhibitor selective for a variant ATP-binding site of the chaperonin GroELEli Chapman, George W Farr, Krystyna Furtak, et al.
Cancer Cell|May 8, 2018
NRF2 and the Hallmarks of CancerMontserrat Rojo de la Vega, Eli Chapman, Donna D Zhang
Pageof 10